Nanobiotix S.A. - Sponsored ADR (NASDAQ: NBTX - Get Free Report)'s stock price gapped down before th

Nanobiotix S.A. - Sponsored ADR (NASDAQ: NBTX - Get Free Report) saw an uptick in trading volume on

PARIS and CAMBRIDGE, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: N

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.82) per share. This is a 583.33 percent de

PARIS and CAMBRIDGE, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ:

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul

Shares of Nanobiotix S.A. - Sponsored ADR (NASDAQ: NBTX - Get Free Report) have been assigned a cons

Guggenheim analyst Paul Jeng assumes Nanobiotix (NASDAQ:NBTX) with a Buy rating and announces Pri

All 24 patients completed treatment with no dose-limiting toxicities, no Grade 3 or higher adverse e

All 24 patients completed treatment with no dose-limiting toxicities, no Grade 3 or higher adverse e

PARIS and CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ:

U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 108.9% to $2.03 during Monday's reg

PARIS, July 30, 2026 (GLOBE NEWSWIRE) -- In accordance with articles L.233-8 II of the French Commer

Nanobiotix is rated a strong speculative Buy, driven by risk-adjusted upside from its JNJ-1900 radio

Nanobiotix is evolving into a capital-light, milestone- and royalty-driven oncology platform with JN

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul

Leerink Partners analyst Jonathan Chang maintains Nanobiotix (NASDAQ:NBTX) with a Outperform and

Completed a follow-on offering in May 2026 for aggregate gross proceeds of approximately €86.1 milli

PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: N

NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic app

PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: N

PARIS and CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

PARIS and CAMBRIDGE, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

PARIS, France and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NA

PARIS and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

PARIS and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

U.S. stock futures lower with Nasdaq down 200 points. XP Inc (XP) falls after reporting lower-than-e

Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial

Preclinical evaluation in mice assessed the potential of the Nanobiotix Nanoprimer to overcome commo

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the p

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 62.82 percent inc

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 137.18 percent de

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of pu

Nanobiotix rejects takeover talk after J&J speculation; stock jumps as analysts weigh momentum s

NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic app

U.S. stocks higher as Dow Jones gains 300 points; El Pollo LoCo Holdings jumps 17.6% on better-than-

U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the p

$71 million in funding would extend Nanobiotix cash visibility into early 2028Transaction enables Na